NCT05114954View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study)

NACompletedINTERVENTIONAL

Enrollment

158

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

March 30, 2023

Conditions

Paroxysmal Atrial Fibrillation

Interventions

DEVICE

CardioPulsesTM pulsed field ablation system

Using pulsed field ablation (PFA) catheter, steerable sheath and pulsed field generator to treat atria fibrillation.

Trial Locations (1)

Unknown

General Hospital of the Northern Theater of the Chinese People's Liberation Army, Shenyang

All Listed Sponsors

lead

Hangzhou Dinova EP Technology Co., Ltd

INDUSTRY

NCT05114954 - Evaluation of the Safety and Efficacy of the CardioPulseTM PuLsed fiEld Ablation SystEm in Patients With Paroxysmal Atrial Fibrillation (PLEASE-AF Study) | Biotech Hunter | Biotech Hunter